The ADA Scientific Sessions showcased advancements in diabetes care, including an AI tool for predicting diabetic retinopathy progression and a glucose sensing and delivery device for Type 1 diabetes. The AI tool improves risk…
Continue Reading
Last year, Eyenuk CEO Kaushal Solanki told MedCity News his company is on a mission to “screen every eye in the world” by leveraging its AI-powered disease detection technologies.
Eyenuk still has a lot of…
Aegis Ventures and Northwell Holdings, the investment arm of the New York-based health system, on Tuesday launched Optain, a company that aims to use AI-backed retinal imaging to catch early signs of disease. The…
Continue Reading
What You Should Know:Today Ascertain, the partnership between Aegis Ventures and Northwell Holdings, announced a $12M seed funding round to launch its first company, Optain, an artificial intelligence (AI) company leveraging retinal imaging to…
Continue Reading
